Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.

paper Cited Public

Authors: Hasin, Deborah S; Saha, Tulshi D; Kerridge, Bradley T; Goldstein, Risë B; Chou, S Patricia; Zhang, Haitao; Jung, Jeesun; Pickering, Roger P; Ruan, W June; Smith, Sharon M; Huang, Boji; Grant, Bridget F
Year: 2015
Journal: JAMA psychiatry
PMID: 26502112
DOI: 10.1001/jamapsychiatry.2015.1858
PMCID: PMC5037576

IMPORTANCE: Laws and attitudes toward marijuana in the United States are becoming more permissive but little is known about whether the prevalence rates of marijuana use and marijuana use disorders have changed in the 21st century. OBJECTIVE: To present nationally representative information on the past-year prevalence rates of marijuana use, marijuana use disorder, and marijuana use disorder among marijuana users in the US adult general population and whether this has changed between 2001-2002 and 2012-2013. DESIGN, SETTING, AND PARTICIPANTS: Face-to-face interviews conducted in surveys of 2 nationally representative samples of US adults: the National Epidemiologic Survey on Alcohol and Related Conditions (data collected April 2001-April 2002; N = 43,093) and the National Epidemiologic Survey on Alcohol and Related Conditions-III (data collected April 2012-June 2013; N = 36,309). Data were analyzed March through May 2015. MAIN OUTCOMES AND MEASURES: Past-year marijuana use and DSM-IV marijuana use disorder (abuse or dependence). RESULTS: The past-year prevalence of marijuana use was 4.1% (SE, 0.15) in 2001-2002 and 9.5% (SE, 0.27) in 2012-2013, a significant increase (P < .05). Significant increases were also found across demographic subgroups (sex, age, race/ethnicity, education, marital status, income, urban/rural, and region). The past-year prevalence of DSM-IV marijuana use disorder was 1.5% (0.08) in 2001-2002 and 2.9% (SE, 0.13) in 2012-2013 (P < .05). With few exceptions, increases in the prevalence of marijuana use disorder between 2001-2002 and 2012-2013 were also statistically significant (P < .05) across demographic subgroups. However, the prevalence of marijuana use disorder among marijuana users decreased significantly from 2001-2002 (35.6%; SE, 1.37) to 2012-2013 (30.6%; SE, 1.04). CONCLUSIONS AND RELEVANCE: The prevalence of marijuana use more than doubled between 2001-2002 and 2012-2013, and there was a large increase in marijuana use disorders during that time. While not all marijuana users experience problems, nearly 3 of 10 marijuana users manifested a marijuana use disorder in 2012-2013. Because the risk for marijuana use disorder did not increase among users, the increase in prevalence of marijuana use disorder is owing to an increase in prevalence of users in the US adult population. Given changing laws and attitudes toward marijuana, a balanced presentation of the likelihood of adverse consequences of marijuana use to policy makers, professionals, and the public is needed.

#	Section	Preview
0	Methods — Samples and Procedures	The 2012–2013 NESARC-III is a nationally representative face-to-face interview survey of 36 309…
1	Methods — Samples and Procedures	found in the percentage Hispanic, black, or Asian; population density; vacancy rate; and proportion…
2	Methods — Samples and Procedures	The 2001–2002 NESARC was a nationally representative face-to-face interview survey of US adults…
3	Methods — Assessments and Quality Assurance	In NESARC-III, past-year DSM-IV marijuana use (defined as any use, consistent with many studies) and…
4	Methods — Assessments and Quality Assurance	In NESARC, the AUDADIS-IV was used to measure marijuana use (also defined as any use) and marijuana…
5	Methods — Assessments and Quality Assurance	Test-retest reliability and validity of AUDADIS-IV marijuana use and marijuana use disorder…
6	Methods — Assessments and Quality Assurance	Interviewer quality-assurance methods were similar across the surveys. As described elsewhere,31,35…
7	Methods — Statistical Analyses	Weighted cross-tabulations estimated the prevalence of marijuana use and marijuana use disorder in…
8	Results — Past-Year Marijuana Use	Past-year marijuana use was reported by 4.1% in 2001–2002 and 9.5% in 2012–2013, a significant…
9	Results — Past-Year DSM-IV Marijuana Use Disorder	The prevalence of DSM-IV marijuana use disorder increased significantly between 2001–2002 (1.5%)…
10	Results — Past-Year DSM-IV Marijuana Use Disorder — Among Marijuana Users	The prevalence of past-year DSM-IV marijuana use disorder among users was 35.6% in 2001–2002 and…
11	Discussion	In 2012–2013, 9.52% of US adults used marijuana in the past year, and 2.9% had a diagnosis of…
12	Discussion	These results differ from the comparison of marijuana use and marijuana use disorders among US…
13	Discussion	The 2001–2002 to 2012–2013 period saw a substantial increase in the prevalence of marijuana use,…
14	Discussion	Further, changing attitudes may also underlie the movement toward marijuana legalization, now…
15	Discussion	in laws and policies (eg, minimum legal drinking age and smoke-free laws) do appear related to…
16	Discussion	Black and Hispanic individuals showed especially notable increases in the prevalence of marijuana…
17	Discussion	When examined by age, young adults were at highest risk for marijuana use disorder in both surveys.…
18	Discussion	The findings of this study contrast with National Survey on Drug Use and Health (NSDUH) data…
19	Discussion	62% increase in emergency department visits involving marijuana [2004–2011],19 and a 3-fold…

Name	Type
12-month marijuana disorder local	phenotype
2001–2002 local	cohort
2012–2013 local	cohort
addiction	phenotype
adolescent recreational marijuana use local	phenotype
adolescents	cohort
Adult General Population local	cohort
adult marijuana use risk local	phenotype
adults	cohort
Adults aged 45 to 64 years local	cohort
Adults aged 65 years and older local	cohort
age	phenotype
Age 45-64	cohort
alcohol	phenotype
American Community Survey 2012 local	cohort
Asian	cohort
AUDADIS-5 local	drug
AUDADIS-IV	drug
Belief that marijuana use is risky local	phenotype
Black	phenotype
black participants	cohort
cannabis use	phenotype
cannabis use disorder	phenotype
comorbidity	phenotype
depression	phenotype
disability	phenotype
DSM-5 marijuana disorder criteria local	phenotype
DSM-IV abuse or dependence criteria local	phenotype
emergency department visits local	phenotype
Emergency department visits involving marijuana local	phenotype
fatal car crashes local	phenotype
Fatal car crashes with cannabis involvement local	phenotype
Hispanic	phenotype
Hispanic individuals	cohort
Income gap local	phenotype
Injury other than road crash local	phenotype
Intoxicated driving local	phenotype
Low income	phenotype
marijuana	phenotype
marijuana abuse	phenotype
marijuana dependence	phenotype
marijuana disorder local	phenotype
marijuana use diagnoses local	phenotype
marijuana use disorder	phenotype
middle-aged adults	cohort
Minority stress local	phenotype
National Survey on Drug Use and Health	cohort
Neighborhood disorder local	phenotype
NESARC	cohort
NESARC-III	cohort
nicotine	drug
NLAES	cohort
NSDUH	cohort
older adults	cohort
past-year marijuana use local	phenotype
Public education about marijuana risks local	phenotype
sex	phenotype
South	cohort
Southern US local	cohort
THC	drug
US adult civilian population local	cohort
US adults 1991-1992 local	cohort
US adults 2001-2002 local	cohort
US adults 2012-2013	cohort
US civilian population	cohort
veterans	cohort
violence	phenotype
Visible drug sales local	phenotype
whites	cohort
women	cohort
Worse treatment outcome for trauma local	phenotype
young adults	cohort
Δ-9-THC local	drug

Citation	PMID	DOI	Status
2014, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings: NSDUH SeriesH-48	—	—	—
Adams, PF et al., Vital Health Stat 10, 2012, Summary health statistics for US adults: National Health Interview Survey	24784762	—	Cited
American Community Survey, 2012, 2013	—	—	—
Anderson, DM et al., Am Law Econ Rev, Medical marijuana laws and teen marijuana use [published online April 24, 2015]	—	—	—
Barrio, G et al., Accid Anal Prev, 2012, Association between cannabis use and non-traffic injuries	22405246	10.1016/j.aap.2012.01.002	Cited
Bonn-Miller, MO et al., Psychol Serv, 2012, Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009	22564034	10.1037/a0027622	Cited
Brady, JE et al., Am J Epidemiol, 2014, Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010	24477748	10.1093/aje/kwt327	Cited
Budney, AJ et al., Am J Psychiatry, 2004, Review of the validity and significance of cannabis withdrawal syndrome	15514394	10.1176/appi.ajp.161.11.1967	Cited
Canino, G et al., J Stud Alcohol, 1999, The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population	10606491	10.15288/jsa.1999.60.790	Cited
Cerdá, M et al., Drug Alcohol Depend, 2012, Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence	22099393	10.1016/j.drugalcdep.2011.06.011	Cited
Chatterji, S et al., Drug Alcohol Depend, 1997, Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule–Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison	9306043	10.1016/s0376-8716(97)00088-4	Cited
Choi, NG et al., Gerontologist, Risk factors for self-reported driving under the influence of alcohol and/or illicit drugs among older adults [published online July 25, 2014]	25063352	10.1093/geront/gnu070	Cited
Choo, EK et al., J Adolesc Health, 2014, The impact of state medical marijuana legislation on adolescent marijuana use	24742758	10.1016/j.jadohealth.2014.02.018	Cited
Compton, WM et al., Drug Alcohol Depend, 2014, Unemployment and substance outcomes in the United States 2002–2010	25042761	10.1016/j.drugalcdep.2014.06.012	Cited
Compton, WM et al., JAMA, 2004, Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002	15126440	10.1001/jama.291.17.2114	Cited
Conway, KP et al., J Clin Psychiatry, 2006, Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions	16566620	10.4088/jcp.v67n0211	Cited
Cottler, LB et al., Drug Alcohol Depend, 1997, Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN	9306045	10.1016/s0376-8716(97)00090-2	Cited
Danovitch, I et al., Psychiatr Clin North Am, 2012, State of the art treatments for cannabis dependence	22640758	10.1016/j.psc.2012.03.003	Cited
Davis, GP et al., Schizophr Res, 2013, Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions	24200416	10.1016/j.schres.2013.10.018	Cited
Di Forti, M et al., Lancet Psychiatry, 2015, Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study	26359901	10.1016/S2215-0366(14)00117-5	Cited
Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits: HHS Publication. No. (SMA) 13-4760: DAWN Series D-39, 2013	—	—	—
Dutra, L et al., Am J Psychiatry, 2008, A meta-analytic review of psychosocial interventions for substance use disorders	18198270	10.1176/appi.ajp.2007.06111851	Cited
ElSohly, MA, Potency Monitoring Program Quarterly Report Number 124: Reporting Period: 12/16/2013-03/15/2014, 2014	—	—	—
Fischer, B et al., Int J Drug Policy, 2015, Medical Marijuana programs: implications for cannabis control policy: observations from Canada	25287942	10.1016/j.drugpo.2014.09.007	Cited
Grant, BF et al., Alcohol Health Res World, 1992, Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992	31798130	—	Cited
Grant, BF et al., Arch Gen Psychiatry, 2004, Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions	15066894	10.1001/archpsyc.61.4.361	Cited
Grant, BF et al., Drug Alcohol Depend, 1995, The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample	7587973	10.1016/0376-8716(95)01134-k	Cited
Grant, BF et al., Drug Alcohol Depend, 2015, The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample	25595052	10.1016/j.drugalcdep.2014.11.026	Cited
Grant, BF et al., JAMA Psychiatry, 2015, Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III	26039070	10.1001/jamapsychiatry.2015.0584	Cited
Grant, BF et al., Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III), 2014	—	—	—
Grant, BF et al., Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), 2003	—	—	—
Grant, BF et al., The Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Version (AUDADIS-5), 2011	—	—	—
Grucza, RA et al., Addiction, 2007, Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys	17309538	10.1111/j.1360-0443.2007.01745.x	Cited
Hall, W, Int J Drug Policy, 2009, The adverse health effects of cannabis use: what are they, and what are their implications for policy?	19362460	10.1016/j.drugpo.2009.02.013	Cited
Haney, M, Curr Psychiatry Rep, 2005, The marijuana withdrawal syndrome: diagnosis and treatment	16216154	10.1007/s11920-005-0036-1	Cited
Hartman, RL et al., Clin Chem, 2013, Cannabis effects on driving skills	23220273	10.1373/clinchem.2012.194381	Cited
Hasin, D et al., Drug Alcohol Depend, 1997, The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample	9088785	10.1016/s0376-8716(97)01332-x	Cited
Hasin, DS et al., Am J Psychiatry, 2013, DSM-5 criteria for substance use disorders: recommendations and rationale	23903334	10.1176/appi.ajp.2013.12060782	Cited
Hasin, DS et al., Drug Alcohol Depend, 2015, The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample	25604321	10.1016/j.drugalcdep.2014.12.011	Cited
Hasin, DS et al., J Clin Psychiatry, 2008, Cannabis withdrawal in the United States: results from NESARC	19012815	10.4088/jcp.v69n0902	Cited
Hasin, DS et al., Lancet Psychiatry, 2015, Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys	26303557	10.1016/S2215-0366(15)00217-5	Cited
Johnston, LD et al., Monitoring the Future National Results on Adolescent Drug Use: Overview of the Key Findings, 2012, 2013	—	—	—
Johnston, LD et al., Use of alcohol, cigarettes, and number of illicit drugs declines among US teens	—	—	—
Kalant, H, Clin Pharmacol Ther, 2015, Cannabis control policy: no rational basis yet for legalization	25778495	10.1002/cpt.112	Cited
Keyes, KM et al., Addiction, 2011, The social norms of birth cohorts and adolescent marijuana use in the United States, 1976–2007	21545669	10.1111/j.1360-0443.2011.03485.x	Cited
Kochhar, R et al., Wealth gaps rise to record highs between whites, blacks, Hispanics: twenty-to-one. Pew Research Center	—	—	—
Kochhar, R et al., Wealth inequality has widened along racial, ethnic lines since end of Great Recession. Pew Research Center	—	—	—
Lank, PM et al., Am J Drug Alcohol Abuse, 2014, Outcomes for older trauma patients in the emergency department screening positive for alcohol, cocaine, or marijuana use	24588418	10.3109/00952990.2014.880450	Cited
Lenné, MG et al., Accid Anal Prev, 2010, The effects of cannabis and alcohol on simulated arterial driving: influences of driving experience and task demand	20380913	10.1016/j.aap.2009.04.021	Cited
Lev-Ran, S et al., Drug Alcohol Depend, 2012, Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions	22143039	10.1016/j.drugalcdep.2011.11.010	Cited
Lindenberg, CS et al., Res Nurs Health, 1993, Empirical evidence for the social stress model of substance abuse	8210473	10.1002/nur.4770160506	Cited
Link, BG et al., Am J Public Health, 1994, Lifetime and five-year prevalence of homelessness in the United States	7998628	10.2105/ajph.84.12.1907	Cited
Lynne-Landsman, SD et al., Am J Public Health, 2013, Effects of state medical marijuana laws on adolescent marijuana use	23763418	10.2105/AJPH.2012.301117	Cited
Lynskey, M et al., Addiction, 2000, The effects of adolescent cannabis use on educational attainment: a review	11219366	10.1046/j.1360-0443.2000.951116213.x	Cited
Marshall, K et al., Cochrane Database Syst Rev, 2014, Pharmacotherapies for cannabis dependence	25515775	10.1002/14651858.CD008940.pub2	Cited
Mason, WA et al., Subst Use Misuse, 2015, Washington State recreational marijuana legalization: parent and adolescent perceptions, knowledge, and discussions in a sample of low-income families	25671633	10.3109/10826084.2014.952447	Cited
Mehmedic, Z et al., J Forensic Sci, 2010, Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008	20487147	10.1111/j.1556-4029.2010.01441.x	Cited
Meier, MH et al., Proc Natl Acad Sci U S A, 2012, Persistent cannabis users show neuropsychological decline from childhood to midlife	22927402	10.1073/pnas.1206820109	Cited
MMWR, 2012, Youth risk behavior surveillance—United States 2011: surveillance summaries	22673000	—	Cited
Nelson, CB et al., Addiction, 1999, Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study	10665074	10.1046/j.1360-0443.1999.9468438.x	Cited
O’Shea, M et al., J Psychopharmacol, 2006, Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats	16714325	10.1177/0269881106065188	Cited
Pacek, LR et al., Drug Alcohol Depend, 2015, Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity	25735467	10.1016/j.drugalcdep.2015.02.009	Cited
Pacula, RL et al., Am J Public Health, 2014, Developing public health regulations for marijuana: lessons from alcohol and tobacco	24825201	10.2105/AJPH.2013.301766	Cited
Pacula, RL et al., J Drug Policy Anal, 2014, Words can be deceiving: a review of variation among legally effective medical marijuana laws in the United States	25657828	10.1515/jdpa-2014-0001	Cited
Pacula, RL et al., J Policy Anal Manage, 2015, Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details	25558490	10.1002/pam.21804	Cited
Palamar, JJ et al., Int J Drug Policy, 2014, Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization	24589410	10.1016/j.drugpo.2014.01.017	Cited
Pull, CB et al., Drug Alcohol Depend, 1997, Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study	9306046	10.1016/s0376-8716(97)00091-4	Cited
Ramaekers, JG et al., Drug Alcohol Depend, 2004, Dose related risk of motor vehicle crashes after cannabis use	14725950	10.1016/j.drugalcdep.2003.10.008	Cited
Ramesh, D et al., Exp Clin Psychopharmacol, 2013, Marijuana’s dose-dependent effects in daily marijuana smokers	23937597	10.1037/a0033661	Cited
Reboussin, BA et al., J Urban Health, 2014, Neighborhood environment and urban African American marijuana use during high school	25323775	10.1007/s11524-014-9909-0	Cited
Rehm, J et al., Clin Pharmacol Ther, 2015, Cannabis legalization with strict regulation, the overall superior policy option for public health	25677377	10.1002/cpt.93	Cited
Release 11, 2012	—	—	—
Renard, J et al., Psychopharmacology (Berl), 2013, Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison	22983145	10.1007/s00213-012-2865-z	Cited
Results from the 2002 National Survey on Drug Use and Health: National Findings, 2003	—	—	—
Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, 2013	—	—	—
Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, Appendix. B. Statistical Methods and Measurement, 2012	—	—	—
Rhodes, JE et al., J Consult Clin Psychol, 1990, A social stress model of substance abuse	2212175	10.1037//0022-006x.58.4.395	Cited
Rubio, JM et al., J Clin Psychiatry, 2013, Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions	23759465	10.4088/JCP.12m08269	Cited
Saad, L, Gallup, Majority continues to support pot legalization in US	—	—	—
Satre, DD et al., Am J Geriatr Psychiatry, 2011, Patterns of alcohol and drug use among depressed older adults seeking outpatient psychiatric services	21788921	10.1097/JGP.0b013e3181f17f0a	Cited
Secades-Villa, R et al., Int J Drug Policy, 2015, Probability and predictors of the cannabis gateway effect: a national study	25168081	10.1016/j.drugpo.2014.07.011	Cited
Sinclair, CF et al., J Health Care Poor Underserved, 2013, Perceptions of harm to health from cigarettes, blunts, and marijuana among young adult African American men	23974397	10.1353/hpu.2013.0126	Cited
Stinson, FS et al., Psychol Med, 2006, Cannabis use disorders in the USA: prevalence, correlates and co-morbidity	16854249	10.1017/S0033291706008361	Cited
van der Pol, P et al., Addiction, 2014, Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study	24628797	10.1111/add.12508	Cited
Volkow, ND et al., N Engl J Med, 2014, Adverse health effects of marijuana use	24897085	10.1056/NEJMra1402309	Cited
Vrasti, R et al., Eur Addict Res, 1998, Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule–Alcohol/Drug-Revised	9852366	10.1159/000018947	Cited
Wall, MM et al., Ann Epidemiol, 2011, Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear	21820632	10.1016/j.annepidem.2011.06.001	Cited
Wen, H et al., J Health Econ, 2015, The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances	25863001	10.1016/j.jhealeco.2015.03.007	Cited
Zhao, J et al., Drug Alcohol Rev, 2009, Non-response bias in alcohol and drug population surveys	19930019	10.1111/j.1465-3362.2009.00077.x	Cited

In this knowledge base

Title	Year	PMID
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.	2021	34806072
Genome-wide association study identifies a novel locus for cannabis dependence.	2018	29112194
Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity.	2017	28938183
Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women.	2017	28779616
Review: Prevalence and co-occurrence of addictions in US ethnic/racial groups: Implications for genetic research.	2017	27759944
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.	2016	27028160
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.	2016	26940807
Recent Trends in the Prevalence of Marijuana Use and Associated Disorders in the United States.	2016	26864618
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women.	2016	27012434

External

Title	Authors	Journal	Year	Link
Differential Responsiveness to Cigarette Prices by U.S. Adults Who Do and Do Not Use Cannabis.	Yao T et al.	—	2026	→
Effects of Legalizing Recreational Cannabis Sales on Cannabis Use and Cannabis-Related Disorder Among Presentations to a Psychiatric Emergency Service.	Foo CYS et al.	—	2026	→
Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units.	Lees Thorne R et al.	—	2026	→
Exploring Recreational Cannabis Use Cessation Intentions among Adults in the United States Using the Multi-Theory Model of Health Behavior Change.	Grigsby TJ et al.	—	2026	→
Impact of cannabis smoking in patients with COPD: A retrospective cross-sectional study in a safety- net hospital.	Cherian SV et al.	—	2026	→
Preoperative Cannabis Use and Ankle ORIF Outcomes: Higher Risks of Infection, Nonunion, and Reoperation.	Tummala S et al.	—	2026	→
Preoperative Cannabis Use Is Associated With Elevated Risk for Complications and Revision Surgery After Anterior Cervical Diskectomy and Fusion.	Tummala S et al.	—	2026	→
Sex and gender influences on problematic cannabis use and cannabis use disorder: A scoping review protocol.	Matheson J et al.	—	2026	→
The impact of cannabis co-use and cannabis use disorder on interest in and barriers to tobacco cessation.	Graham FJL et al.	—	2026	→
The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives.	Baldasso GM et al.	—	2026	→
Trends in Post Legalization Cannabis Use Among Ethnic Groups in California: 2018-2023.	Caetano R et al.	—	2026	→
An Analysis of 16-Year Trends in Cannabis Use Disorder Treatment: Predictors, Barriers, and Utilization Patterns.	Graves BD et al.	—	2025	→
Brief exposure to (-) THC affects zebrafish embryonic locomotion with effects that persist into the next generation.	Amin MR et al.	—	2025	→
Cannabinoid hyperemesis syndrome: A review.	Jiménez-Castillo RA et al.	—	2025	→
Cannabis.	Feinberg SD et al.	—	2025	→
Cannabis and Dermatological Implications: A Traditional Review of Adverse Cutaneous Reactions and Systemic Risks.	Shrivastava S et al.	—	2025	→
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey.	Mgebrishvili T et al.	—	2025	→
Cannabis effects on cardiovascular health: Current evidence, gaps in knowledge, and future research directions.	Mahmoud AK et al.	—	2025	→
Cannabis legalization and cannabis use disorder in United States Veterans Health Administration patients with and without psychiatric disorders, 2005-2022: a repeated cross-sectional study.	Hasin DS et al.	—	2025	→
Cannabis Use Among Older Adults.	Pravosud V et al.	—	2025	→
Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013.	Hasin DS et al.	—	2025	→
Cannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights (Review).	Georgakopoulou VE et al.	—	2025	→
Changing Developmental Patterns of Cannabis and Alcohol Use in Washington State: an Analysis of Young Adult Birth Cohorts Born in 1990-2004.	Acolin J et al.	—	2025	→
Comorbid Cannabis Use and Mood Disorders Among Adolescents.	Strong SJ et al.	—	2025	→
Cumulative Adverse Childhood Experiences and Frequency of Substance Use Among US High School Students.	Azagba S et al.	—	2025	→
Disparities in use modalities among adults who currently use cannabis, 2022-2023.	Diaby M et al.	—	2025	→
Distinct circulating monocyte profiles in chronic cannabis users compared to cocaine users without changes in plasma levels of proinflammatory cytokines and LPS.	Johnson D et al.	—	2025	→
Effect of Preoperative Marijuana on Patient Outcomes and Opioid Use after Lumbar Decompression.	Trenchfield D et al.	—	2025	→
Exploration of Cannabis Use with Excessive Social Media Use Among U.S. College Students.	Hill MJ et al.	—	2025	→
Gender differences in cannabis outcomes after recreational legalization: a United States repeated cross-sectional study, 2008-2017.	Segura LE et al.	—	2025	→
Identifying predictors of multi-year cannabis vaping in U.S. Young adults using machine learning.	Choe S et al.	—	2025	→
In Vitro Exposure to Vaped Tetrahydrocannabinol Increases <i>Candida albicans</i> (SC5314) Growth, Metabolic Activity, Biofilm Formation, and the Expression of Virulence Genes.	Laaboudi FZ et al.	—	2025	→
Lifetime Cannabis Use Is Associated with Brain Volume and Cognitive Function in Middle-Aged and Older Adults.	Guha A et al.	—	2025	→
Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications.	Agrawal SP et al.	—	2025	→
Marijuana Use and Complication Risk After Tibia Shaft Fracture Fixation.	Maxson R et al.	—	2025	→
Momentary mindfulness versus distraction coping messages to reduce cannabis craving among young adults: A microrandomized trial.	Stanger C et al.	—	2025	→
Neural basis of adolescent THC-induced potentiation of opioid responses later in life.	Hubbard E et al.	—	2025	→
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post-legalization era.	Bahji A	—	2025	→
Partner Violence and Substance-Related Service Use: Differences by HIV Status Among Women.	Ogden SN et al.	—	2025	→
Patterns of past month cannabis consumption and cannabis use disorder - Insights from a nationally representative survey.	Kritikos AF et al.	—	2025	→
Prevalence of Cannabis Use Disorder: A Meta-Analysis of Population Surveys.	Boness CL et al.	—	2025	→
Rasch Analysis of Cannabis Use Disorder in an Adult Inpatient Sample.	Gendy MNS et al.	—	2025	→
Recreational marijuana legalization and marijuana and alcohol co-use among adolescents: Differential associations among racial and ethnic groups.	García-Ramírez G et al.	—	2025	→
Regulatory sandboxes as an innovative platform for testing Cannabis edibles in Germany.	Al Hallaj H et al.	—	2025	→
Rescheduling Cannabis-Medicine or Politics?	Madras BK et al.	—	2025	→
Rest-activity rhythms in individuals who separately or concomitantly use cannabis and cigarettes.	Hebl J et al.	—	2025	→
Safety considerations for patients using cannabis.	Dugan SE	—	2025	→
Sex differences in normative modeling of cortical thickness in cannabis use disorder.	Martin EL et al.	—	2025	→
The Impact of Medical Cannabis Laws on Cannabis and Opioid Use Disorder Treatment and Overdose-Related Health Care Utilization Among Adults With Chronic Noncancer Pain.	McGinty EE et al.	—	2025	→
The impact of the home life environment and organised extracurricular activities on adolescent cannabis use: Findings from the Irish Planet Youth Survey.	Daly FP et al.	—	2025	→
Understanding the online landscape of cannabis discourse: a Twitter analysis.	Alvarez-Mon MA et al.	—	2025	→
Ventricular Repolarization in Healthy Young Adults Who Use Combusted Cannabis: A Cross-Sectional Parallel Group Comparison Study.	Hampilos K et al.	—	2025	→
What proportion of people who use cannabis in Germany have spoken with their general practitioner about their consumption? A repeated cross-sectional representative population survey.	Borchardt B et al.	—	2025	→
Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently.	Livne O et al.	—	2024	→
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder.	Sahlem GL et al.	—	2024	→
Association of cannabis use with patient-reported pain measures among adults with chronic pain in US states with medical cannabis programs.	Bicket MC et al.	—	2024	→
Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.	Havlik JL et al.	—	2024	→
Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.	Mauro PM et al.	—	2024	→
Associations of cannabis use and body mass index-The Coronary Artery Risk Development in Young Adults (CARDIA) study.	Jakob J et al.	—	2024	→
Atrial Fibrillation Occurring After Smoking Marijuana: A Case Report and Review of the Literature.	Unanyan M et al.	—	2024	→
Brain Function and Marijuana: Are there Changes after Abstinence of Consumption? Preliminary Results.	Neubauer S et al.	—	2024	→
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.	Kumar U	—	2024	→
Cannabis use and social anxiety disorder in emerging adulthood: Results from a nationally representative sample.	Single A et al.	—	2024	→
Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample.	Rubin-Kahana DS et al.	—	2024	→
Cannabis use Disorder and Complications After Anterior Cervical Diskectomy and Fusion.	Van Halm-Lutterodt N et al.	—	2024	→
Cannabis use disorder and perioperative outcomes following complex cancer surgery.	Munir MM et al.	—	2024	→
Cannabis Use Disorder Is Associated With Longer In-Hospital Lengths of Stay, Higher Rates of Medical Complications, and Costs of Care Following Primary 1- to 2-Level Lumbar Fusion.	Jain S et al.	—	2024	→
Cannabis use disorders and outcome of admission to intensive care: A retrospective multi-centre cohort study.	Renger L et al.	—	2024	→
Cannabis use in youth is associated with chronic inflammation.	Power E et al.	—	2024	→
Cannabis use, oral dysbiosis, and neurological disorders.	Hazzard AA et al.	—	2024	→
Cannabis Use Reported by Patients Receiving Primary Care in a Large Health System.	Gelberg L et al.	—	2024	→
Co-occurrence of mental illness and substance use among US pregnant individuals, 2012-2021.	Li Z et al.	—	2024	→
Daily associations with cannabis use and sleep quality in anxious cannabis users.	Bidwell LC et al.	—	2024	→
Decomposing the late positive potential to cannabis cues in regular cannabis users: A temporal-spatial principal component analysis.	Preston TJ et al.	—	2024	→
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol.	Khazaee-Pool M et al.	—	2024	→
Development of Mobile Contingency Management for Cannabis Use Reduction.	Beckham JC et al.	—	2024	→
Does Marijuana Smoking Increase the Odds of Surgical Site Infection After Orthopaedic Surgery? A Retrospective Cohort Study.	Ruckle D et al.	—	2024	→
Drug driving: a secondary analysis of factors associated with driving under the influence of cannabis in Jamaica.	Lalwani K et al.	—	2024	→
Examination of Rumination's Mediating Role in the Relation Between Distal Personality Predictors, Cannabis Coping Motives, and Negative Cannabis-Related Consequences.	Conner BT et al.	—	2024	→
Examining the Popularity, Content, and Intersections With the Substance Abuse and Mental Health Services Administration's Definition of Recovery in a Nonclinical Online Cannabis Cessation Community: Infodemiology Study of Reddit Posts.	Thulin EJ et al.	—	2024	→
Exploration Into Patterns of Cannabis Use Across Pregnancy and Postpartum.	Eitel AE et al.	—	2024	→
Extending Gender- and Sex-Based Analyses in Cannabis Research: Findings from an Online Sample of Gender Diverse Young Adult Consumers.	Struble CA et al.	—	2024	→
"I don't need my kid to be high": prioritizing harm reduction when using cannabis during pregnancy.	Gould EE et al.	—	2024	→
In-Home Cannabis Smoking Among a Cannabis-Using Convenience Sample from the Global Drug Survey: With Weighted Estimates for U.S. Respondents.	Tripathi O et al.	—	2024	→
Latent Trajectories of Persistence of Cannabis Use Across Four Decades in 329 Men From the San Diego Prospective Study.	Schuckit MA et al.	—	2024	→
Neural circuit basis of adolescent THC-induced potentiation of opioid responses later in life	Hubbard E et al.	—	2024	—
Neuromodulation for Cannabis Use: A Scoping Review.	Ngoy A et al.	—	2024	→
Nicotine and cannabis routes of administration and dual use among U.S. young adults who identify as Hispanic, non-Hispanic Black, and non-Hispanic White.	Pulvers K et al.	—	2024	→
Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis.	Salz T et al.	—	2024	→
Perceived Risks and Benefits and Frequency of Cannabis Use Among People with HIV in Different Legal Environments.	Laper S et al.	—	2024	→
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.	Das A et al.	—	2024	→
Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.	Tadesse AW et al.	—	2024	→
Prevalence and correlates of severe problematic cannabis use: analysis of a population-based survey in Jamaica.	Lalwani K et al.	—	2024	→
Prevalence and Treatment of Substance Misuse in Older Adults: Beyond Early Adulthood.	Hu J et al.	—	2024	→
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA.	Alexander GD et al.	—	2024	→
Screening problematic use of substances among young subjects attending an emergency department, and subsequent treatment seeking.	Touali R et al.	—	2024	→
The association between marijuana and e-cigarette use and exercise behavior among adults.	Boutouis S et al.	—	2024	→
The influence of drug class on reward in substance use disorders.	Jones JD et al.	—	2024	→
The neural oscillations serving task switching are altered in cannabis users.	McDonald KM et al.	—	2024	→
The subjective value of social context in people who use cannabis.	Shellenberg TP et al.	—	2024	→
Trends in coping reasons for marijuana use among U.S. adolescents from 2016 to 2022.	Patrick ME et al.	—	2024	→
Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022.	Gorfinkel LR et al.	—	2024	→
Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019.	Livne O et al.	—	2024	→
Understanding Pharmacy Students' Preparedness towards Counseling over Cannabis Use Disorder.	Ganna S et al.	—	2024	→
What Parents Are Missing: Parental Knowledge of Adult-Use Cannabis Legislation and Health Effects, and Communication with Adolescents.	Adewale CA et al.	—	2024	→
Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021.	Hasin DS et al.	—	2023	→
Adverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohort.	Hines LA et al.	—	2023	→
Adverse Events After Ankle Fracture Open Reduction Internal Fixation Among Patients With and Without Documented Cannabis and Tobacco Use.	Dhodapkar MM et al.	—	2023	→
Alcohol and Cannabis Use Within Emerging Adults' Committed Romantic Relationships: Associations with Relationship Functioning and Quality of Life.	Tucker JS et al.	—	2023	→
A longitudinal mediational investigation of risk pathways among cannabis use, interpersonal trauma exposure, and trauma-related distress.	Hicks TA et al.	—	2023	→
A randomized controlled trial of brief intervention for patients with cannabis use disorder.	Shekhawat AS et al.	—	2023	→
Attitudes of medical students regarding legalisation of cannabis and cannabis-education.	Eiselen E et al.	—	2023	→
Cannabis and Pregnancy: A Review.	Hayer S et al.	—	2023	→
Cannabis industry campaign expenditures in Colorado, 2005-2021.	Rotering T et al.	—	2023	→
Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies.	Xiao KB et al.	—	2023	→
Cannabis use among adolescents and emerging adults who use e-cigarettes: Findings from an online, national U.S. Sample.	Croker JA et al.	—	2023	→
Cannabis use among recently treated cancer patients: perceptions and experiences.	Salz T et al.	—	2023	→
Cannabis use and sleep disturbances among White, Black, and Latino adults in the United States: A cross-sectional study of National Comorbidity Survey-Replication (2001-2003) data.	Gaston SA et al.	—	2023	→
Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study.	Brown QL et al.	—	2023	→
Cannabis Use Disorder and Perioperative Complications.	Potnuru PP et al.	—	2023	→
Cannabis use disorder, suicide attempts, and self-harm among adolescents: A national inpatient study across the United States.	Oladunjoye AF et al.	—	2023	→
Cannabis use for medical symptoms: Patterns over the first year of use.	Gilman JM et al.	—	2023	→
Cannabis use in context: Relations among impulsive personality traits, context, and cannabis problems.	Waddell JT et al.	—	2023	→
Cannabis Use in Patients with Gastroparesis.	Saleem S et al.	—	2023	→
Characterization of quality of life among individuals with current treated, untreated, and past alcohol use disorder.	Havlik JL et al.	—	2023	→
Chronic exposure to inhaled vaporized cannabis high in Δ9-THC alters brain structure in adult female mice.	Taylor A et al.	—	2023	→
Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study.	Hasin DS et al.	—	2023	→
Comparing the diagnostic performance of ordinary, mixed, and lasso logistic regression models at identifying opioid and cannabinoid poisoning in U.S. dogs using pet demographic and clinical data reported to an animal poison control center (2005-2014).	Howard-Azzeh M et al.	—	2023	→
Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership.	Cooke ME et al.	—	2023	→
Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.	Shmulewitz D et al.	—	2023	→
Does sleep relate to next-day cannabis use during treatment? Findings from an adolescent and young adult motivational enhancement and cognitive behavioral therapy plus topiramate intervention.	Parnes JE et al.	—	2023	→
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia-spectrum disorders?	Yeap ZJS et al.	—	2023	→
Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial.	Baltes-Flueckiger L et al.	—	2023	→
Epidemiology and factors associated with cannabis use among patients with glaucoma in the <i>All of Us</i> Research Program.	Wu JH et al.	—	2023	→
Genome-wide DNA methylation association study of recent and cumulative marijuana use in middle aged adults.	Nannini DR et al.	—	2023	→
Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder.	Afshar K et al.	—	2023	→
Impact of cannabis use on brain metabolism using <sup>31</sup>P and <sup>1</sup>H magnetic resonance spectroscopy.	Fenzl M et al.	—	2023	→
Impacts of recreational cannabis legalization on use and harms: A narrative review of sex/gender differences.	Matheson J et al.	—	2023	→
Impairment of Endothelial Function by Aerosol From Marijuana Leaf Vaporizers.	Liu J et al.	—	2023	→
Is pre-college interpersonal trauma associated with cannabis use?	Hicks TA et al.	—	2023	→
Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the "high-risk" addiction patient.	Black T	—	2023	→
Long-term effects of THC exposure on reward learning and motivated behavior in adolescent and adult male rats.	Halbout B et al.	—	2023	→
Long-Term Outcomes of Adolescent THC Exposure on Translational Cognitive Measures in Adulthood in an Animal Model and Computational Assessment of Human Data.	Ferland JN et al.	—	2023	→
Marijuana Use is Not a Contraindication for Tranexamic Acid Utilization in Lumbar Spine Surgery.	Jakoi AM et al.	—	2023	→
Mental and Physical Health Conditions Among U.S. Veterans with Cannabis Use and Cannabis Use Disorders.	Livne O et al.	—	2023	→
Mental health and cannabis use among Canadian youth: Integrated findings from cross-sectional and longitudinal analyses.	Butler A et al.	—	2023	→
Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies.	Xu H et al.	—	2023	→
Molecular insights into GPCR mechanisms for drugs of abuse.	Sanchez-Reyes OB et al.	—	2023	→
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications.	Levey DF et al.	—	2023	→
Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity.	Fataar F et al.	—	2023	→
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021.	Chambers J et al.	—	2023	→
Physical inactivity during adolescence heightens risk for cannabis use disorder in adulthood.	Tarter RE et al.	—	2023	→
Potential neonatal toxicity of new psychoactive substances.	Fujiwara R et al.	—	2023	→
Predictors of Cannabis Use Among Canadian University Students.	Llewelyn-Williams J et al.	—	2023	→
Predictors of Empirically Derived Substance Use Patterns Among Sexual and Gender Minority Populations of a Rural Midwestern State.	Baker E et al.	—	2023	→
Prevalence and trends of common mental disorders from 2007-2009 to 2019-2022: results from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS), including comparison of prevalence rates before vs. during the COVID-19 pandemic.	Ten Have M et al.	—	2023	→
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.	Lapham GT et al.	—	2023	→
Role of neuronal nicotinic acetylcholine receptors in cannabinoid dependence.	Buzzi B et al.	—	2023	→
Screening, brief intervention, and referral to treatment (SBIRT) for cannabis: A scoping review.	Gette JA et al.	—	2023	→
Sensation Seeking and Substance use in Chinese Adolescents: Longitudinal Trajectories and Prospective Within-person Associations.	Shen T et al.	—	2023	→
Sex differences in Cannabis use disorder and associated psychosocial problems among US adults, 2012-2013.	Gutkind S et al.	—	2023	→
Sex differences in the subjective and reinforcing effects of smoked cannabis.	Lake S et al.	—	2023	→
State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.	Hasin DS et al.	—	2023	→
The association between preconception cannabis use and depression and anxiety during pregnancy.	Leng QL et al.	—	2023	→
The effect of marijuana use on short-term outcomes with bariatric surgery.	Janes LA et al.	—	2023	→
The impact of recreational cannabis laws on cannabis use disorder during "treat and release" visits to hospital emergency departments in four U.S. states, 2017-2020.	Kurtzman ET et al.	—	2023	→
The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders.	Asch RH et al.	—	2023	→
Thoughtful Phenotype Definitions Empower Participants and Power Studies.	Huckins LM	—	2023	→
Transcriptome-wide association study by different approaches reveals candidate causal genes for cannabis use disorder.	Gao J et al.	—	2023	→
Trends in Cannabis-positive Urine Toxicology Test Results: US Veterans Health Administration Emergency Department Patients, 2008 to 2019.	Fink DS et al.	—	2023	→
Trends in public attitudes to permitting cannabis for recreational use: analysis of Irish survey data since 2002.	Mongan D et al.	—	2023	→
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use.	Johnstad PG	—	2023	→
Unravelling the landscape of <i>Cannabis</i> craving pharmacological treatments: a PRISMA-guided review of evidence.	Preto MC et al.	—	2023	→
When prohibition works: Comparing fireworks and cannabis regulations, markets, and harms.	Caulkins JP et al.	—	2023	→
Δ<sup>9</sup> -Tetrahydrocannabinol self-administration induces cell type-specific adaptations in the nucleus accumbens core.	Garcia-Keller C et al.	—	2023	→
An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.	Hinckley JD et al.	—	2022	→
An examination of the acquired preparedness model among college student marijuana users.	Berey BL et al.	—	2022	→
An Exploration of Self-Reported Medicinal Cannabis Use Among a Sample of Eastern Canadian Postsecondary Students.	Smith J et al.	—	2022	→
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders.	Stull SW et al.	—	2022	→
A Scoping Review of Data Sources for the Conduct of Policy-Relevant Substance Use Research.	Geissler KH et al.	—	2022	→
Assessing Increases in Cannabis-Related Diagnoses in US Hospitals by Regional Policy Status.	Pottieger M et al.	—	2022	→
Association of Cannabis Use-Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001-2002 and 2012-2013.	Livne O et al.	—	2022	→
Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.	Kim C et al.	—	2022	→
Associations of Cannabis Use across Adolescence and Early Adulthood With Health and Psychosocial Adjustment in Early Adulthood and Midadulthood in Men.	Capaldi DM et al.	—	2022	→
Behavioral economic interactions between cannabis and alcohol purchasing: Associations with disordered use.	Dolan SB et al.	—	2022	→
Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations.	Winder GS et al.	—	2022	→
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?	Rømer Thomsen K et al.	—	2022	→
Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers.	Venegas A et al.	—	2022	→
Cannabis Use Disorder: A Behavioral Economic Perspective.	Aston ER et al.	—	2022	→
Childhood polyvictimization and marijuana use trajectories.	Plummer Lee C et al.	—	2022	→
Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function.	Reitsma SE et al.	—	2022	→
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis.	D'Souza DC et al.	—	2022	→
Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.	Fink DS et al.	—	2022	→
Correlates of Perceived Harmfulness of Regular Cannabis Use among Canadian University Students Before and After Legalization.	Mader J et al.	—	2022	→
Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context.	Mauro PM et al.	—	2022	→
Delayed presentation of cannabis induced pancreatitis.	Song D et al.	—	2022	→
Disparities in functioning from alcohol and cannabis use among a racially/ethnically diverse sample of emerging adults.	D'Amico EJ et al.	—	2022	→
Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial.	Gilman JM et al.	—	2022	→
Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence.	Zuo CS et al.	—	2022	→
Equity in Coverage of Local Cannabis Control Policies in California, 2020‒2021.	Matthay EC et al.	—	2022	→
Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance.	Stevens AK et al.	—	2022	→
Explainable machine learning analysis reveals sex and gender differences in the phenotypic and neurobiological markers of Cannabis Use Disorder.	Niklason GR et al.	—	2022	→
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging adults: a qualitative study.	Kennedy DP et al.	—	2022	→
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017-19.	Keyes KM et al.	—	2022	→
Impulsivity, Depressive Mood, and Cannabis Use in a Representative Sample of French-Speaking Swiss Young Men.	Rochat L et al.	—	2022	→
Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use.	Sofis MJ et al.	—	2022	→
Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.	Livingston NA et al.	—	2022	→
Lower dACC glutamate in cannabis users during early phase abstinence.	Zuo CS et al.	—	2022	→
Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects.	Tumati S et al.	—	2022	→
Moral injury and cannabis use disorder among Israeli combat veterans: The role of depression and perceived social support.	Ashwal-Malka A et al.	—	2022	→
Nonmedical Marijuana Use and Cardiovascular Events: A Systematic Review.	Yang PK et al.	—	2022	→
Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.	Enkema MC et al.	—	2022	→
Perceived neighborhood disorder and frequency of marijuana use among emerging adult African American females.	Floyd LJ	—	2022	→
Prevalence and correlates of cannabis abuse among residents in the community of Fort McMurray, a city in Northern Alberta which had endured multiple natural disasters.	Obuobi-Donkor G et al.	—	2022	→
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).	Browne KC et al.	—	2022	→
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.	Hill KP et al.	—	2022	→
Self-reported marijuana use and its effects on overall approval in potential living kidney donors.	Cholin LK et al.	—	2022	→
Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review.	French MT et al.	—	2022	→
Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans.	Asper A et al.	—	2022	→
Spatial, temporal, and space-time clusters associated with opioid and cannabis poisoning events in U.S. dogs (2005-2014).	Howard-Azzeh M et al.	—	2022	→
The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls.	Lawn W et al.	—	2022	→
The Coronary Artery Risk Development in Young Adults (CARDIA) Study.	Jakob J et al.	—	2022	→
The Impact of Cannabis Packaging Characteristics on Perceptions and Intentions.	Kowitt SD et al.	—	2022	→
The sentinel role of forensic toxicology laboratories to identify and act upon diverse drug threats by addressing toxicology and economic demands.	Ropero Miller JD et al.	—	2022	→
Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study.	Singh JA	—	2022	→
Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019.	Hasin DS et al.	—	2022	→
Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys.	Berberian S et al.	—	2022	→
Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults.	Lorenz DR et al.	—	2021	→
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health.	Schlienz NJ et al.	—	2021	→
Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli.	Smiley CE et al.	—	2021	→
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.	Rootman JM et al.	—	2021	→
Alarming trends in the frequency of malignant hypertension among admissions with a known cannabis use disorder.	Fong HK et al.	—	2021	→
A Latent Transition Analysis of Self-Reported Reasons for Marijuana Use During Young Adulthood.	Bray BC et al.	—	2021	→
Alcohol and cannabis motives: Differences in daily motive endorsement on alcohol, cannabis, and alcohol/cannabis co-use days in a cannabis-using sample.	Arterberry BJ et al.	—	2021	→
Altered cerebellar-cortical resting-state functional connectivity in cannabis users.	Schnakenberg Martin AM et al.	—	2021	→
A quadripartite model of passion for marijuana use: Associations with consumption, consequences, craving, and satisfaction with life.	Dolan S et al.	—	2021	→
Are Sweet Dreams Made of These? Understanding the Relationship Between Sleep and Cannabis Use.	Edwards D et al.	—	2021	→
Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study.	Sagar KA et al.	—	2021	→
Assessing New Zealand's Cannabis Legalization and Control Bill: prospects and challenges.	Wilkins C et al.	—	2021	→
Association between marijuana use and electrocardiographic abnormalities by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study.	Jakob J et al.	—	2021	→
Attitudes and beliefs about recreational cannabis legalization among cannabis-using young adults in Los Angeles: Impact on concurrent cannabis practices and problematic cannabis use.	Wong CF et al.	—	2021	→
Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018.	Chouairi F et al.	—	2021	→
Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States.	Chiu RG et al.	—	2021	→
Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.	Schlag AK et al.	—	2021	→
Cannabis, Impaired Driving, and Road Safety: An Overview of Key Questions and Issues.	Brands B et al.	—	2021	→
Cannabis-induced oceanic boundlessness.	Earleywine M et al.	—	2021	→
Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes.	Bandoli G et al.	—	2021	→
Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample.	Do EK et al.	—	2021	→
Cannabis use and cannabis use disorder.	Connor JP et al.	—	2021	→
Cannabis use, attitudes, regulation and health: Survey data from an urban population of users and non-users.	Znoj H et al.	—	2021	→
Cannabis use disorder and perioperative outcomes in vascular surgery.	McGuinness B et al.	—	2021	→
Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study.	Gabrhelík R et al.	—	2021	→
Cannabis use outcomes by past-month binge drinking status in the general United States population.	Vijapur SM et al.	—	2021	→
Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss.	Mumford SL et al.	—	2021	→
Cigarette Use and Cannabis Use Disorder Onset, Persistence, and Relapse: Longitudinal Data From a Representative Sample of US Adults.	Weinberger AH et al.	—	2021	→
Comment on: Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis.	Singh JA	—	2021	→
Correlates of Cannabis Use Disorders among urban women of color: childhood abuse, relationship with spouse/partner, and media exposure.	Lee JY et al.	—	2021	→
Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019.	Han BH et al.	—	2021	→
Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013-2017 Traffic Safety Culture Index.	Benedetti MH et al.	—	2021	→
Development and validation of a cannabis cue stimulus set.	Macatee RJ et al.	—	2021	→
Differential Cognitive Performance in Females and Males with Regular Cannabis Use.	Schnakenberg Martin AM et al.	—	2021	→
Down and High: Reflections Regarding Depression and Cannabis.	Langlois C et al.	—	2021	→
Endocannabinoids, cannabinoids and the regulation of anxiety.	Petrie GN et al.	—	2021	→
Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions.	Robinson N et al.	—	2021	→
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets.	Pedersen ER et al.	—	2021	→
Exploring Impact of Marijuana (Cannabis) Abuse on Adults Using Machine Learning.	Choi J et al.	—	2021	→
Homegrown perceptions about the medical use and potential abuse of CBD and THC.	McFadden BR et al.	—	2021	→
Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial.	Macatee RJ et al.	—	2021	→
Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women.	Sherman BJ et al.	—	2021	→
Local variation in cannabis use patterns among young adults in the San Francisco Bay Area.	Holmes LM et al.	—	2021	→
Marijuana Legalization in Colorado: Increasing Potency, Changing Risk Perceptions, and Emerging Public Health Concerns for Youth.	Hinckley JD et al.	—	2021	→
Marijuana use among adult liver transplant candidates and recipients.	Likhitsup A et al.	—	2021	→
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities.	Perlman AI et al.	—	2021	→
Medical Marijuana: Liability Issues for Mental Health Providers.	Kameg B et al.	—	2021	→
Momentary coping and marijuana use in treated adults: Exploring mechanisms of treatment.	Litt MD et al.	—	2021	→
Multidirectional Pathways of Tobacco and Marijuana Use, Including Comorbid Use, Among Young Adults (Aged 18-25 Years) in Texas: A Six-Wave Cross-Lagged Model.	Rogers SM et al.	—	2021	→
Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice.	Humburg BA et al.	—	2021	→
Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada.	Winstock AR et al.	—	2021	→
Post-legalization changes in marijuana use in a sample of young California adults.	Doran N et al.	—	2021	→
Prevalence and correlates of daily blunt use among U.S. African American, Hispanic, and White adults from 2014 to 2018.	Mantey DS et al.	—	2021	→
Prevalence and Correlates of Driving Under the Influence of Cannabis in the U.S.	Salas-Wright CP et al.	—	2021	→
Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019-2020 National Health and Resilience in Veterans Study.	Hill ML et al.	—	2021	→
Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults.	Gutkind S et al.	—	2021	→
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.	Lees R et al.	—	2021	→
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.	Manthey J et al.	—	2021	→
Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention.	Stephens RS et al.	—	2021	→
Recreational Marijuana Legalization and Use Among California Adolescents: Findings From a Statewide Survey.	Paschall MJ et al.	—	2021	→
Relationship between cannabis use and psychotic experiences in college students.	Wright AC et al.	—	2021	→
Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review.	Hudson A et al.	—	2021	→
Self-reported driving after marijuana use in association with medical and recreational marijuana policies.	Benedetti MH et al.	—	2021	→
Sex-dependent effects of alcohol administration on the urge to use cannabis.	Venegas A et al.	—	2021	→
Sexual Minority Status and Marijuana Initiation during Adulthood: A Longitudinal Study Using Nationally Representative Data.	Mantey DS et al.	—	2021	→
The state of the evidence on the association between state cannabis laws and opioid-related outcomes: A review.	Tormohlen KN et al.	—	2021	→
The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.	Shmulewitz D et al.	—	2021	→
Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.	Goodwin RD et al.	—	2021	→
Trends over time in adult cannabis use: A review of recent findings.	Hasin D et al.	—	2021	→
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.	Hasin DS et al.	—	2021	→
Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial.	McRae-Clark AL et al.	—	2021	→
Which came first: Cannabis use or deficits in impulse control?	Rinehart L et al.	—	2021	→
Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR.	Brown GW et al.	—	2021	→
A framework for indirect elicitation of the public health impact of gambling problems.	Browne M et al.	—	2020	→
An exploratory study of cannabis use pattern and treatment seeking in patients attending an addiction treatment facility.	Sarkar S et al.	—	2020	→
A Review of Cases of Marijuana and Violence.	Miller NS et al.	—	2020	→
Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016.	Gorfinkel LR et al.	—	2020	→
A web-based episodic specificity and future thinking session modulates delay discounting in cannabis users.	Sofis MJ et al.	—	2020	→
Cannabinoid-Induced Brugada Syndrome: A Case Report.	Stockholm SC et al.	—	2020	→
Cannabis and work: Need for more research.	Howard J et al.	—	2020	→
Cannabis-Induced Catatonia: A Case Series.	Mekala H et al.	—	2020	→
Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization.	Weinberger AH et al.	—	2020	→
Cannabis Use and the Risk for Psychosis and Affective Disorders.	Sideli L et al.	—	2020	→
Cannabis use and the sperm epigenome: a budding concern?	Schrott R et al.	—	2020	→
Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review.	Hasin D et al.	—	2020	→
Cannabis use, cognitive performance, and symptoms of attention deficit/hyperactivity disorder in community adults.	Petker T et al.	—	2020	→
Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization.	Ecker AH et al.	—	2020	→
Cannabis Use in Hospitalized Patients with Chronic Pain.	Orhurhu V et al.	—	2020	→
Cannabis Use in Inpatients With Schizophrenia Spectrum Disorders at a Community Hospital.	Olayinka O et al.	—	2020	→
Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.	Fuster D et al.	—	2020	→
Cannabis use, problem-gambling severity, and psychiatric disorders: Data from the National Epidemiological Survey on Alcohol and Related Conditions.	Hammond CJ et al.	—	2020	→
Care of the Patient Using Cannabis.	Williams AR et al.	—	2020	→
Cigarette smoking quit ratios among adults in the USA with cannabis use and cannabis use disorders, 2002-2016.	Weinberger AH et al.	—	2020	→
Clearing the air: A study of cannabis-related presentations to urban Alberta emergency departments following legalization.	Yeung MEM et al.	—	2020	→
Concerning trends in cardiogenic shock-related admissions among United States cannabis users.	Lodhi MU et al.	—	2020	→
Craving is impermanent and it matters: Investigating craving and cannabis use among young adults with problematic use interested in reducing use.	Enkema MC et al.	—	2020	→
Deconstructing the neurobiology of cannabis use disorder.	Ferland JN et al.	—	2020	→
Demographic Discrepancies in Prenatal Urine Drug Screening in Washington State Surrounding Recreational Marijuana Legalization and Accessibility.	Pflugeisen BM et al.	—	2020	→
Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study.	Starrels JL et al.	—	2020	→
Disconcerting levels of alcohol use among Venezuelan immigrant adolescents in the United States.	Salas-Wright CP et al.	—	2020	→
Early and Late Adolescent Factors that Predict Co-use of Cannabis with Alcohol and Tobacco in Young Adulthood.	D'Amico EJ et al.	—	2020	→
Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors.	De Gregorio D et al.	—	2020	→
Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood.	Macías-Triana L et al.	—	2020	→
Extension of the Theory of Planned Behavior (TPB) to Predict Patterns of Marijuana Use among Young Iranian Adults.	Jalilian F et al.	—	2020	→
FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.	Kleinhans NM et al.	—	2020	→
Higher odds and rising trends in arrhythmia among young cannabis users with comorbid depression.	Desai R et al.	—	2020	→
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).	Jones S et al.	—	2020	→
Indirect estimation of student marijuana consumers population in Hamadan using PRM and NSU methods.	Halimi L et al.	—	2020	→
Individualized assessment and treatment program (IATP) for cannabis use disorder: Randomized controlled trial with and without contingency management.	Litt MD et al.	—	2020	→
Interaction of Cannabis Use and Aging: From Molecule to Mind.	Yoo HB et al.	—	2020	→
Is Recovery from Cannabis Dependence Possible? Factors that Help or Hinder Recovery in a National Sample of Canadians with a History of Cannabis Dependence.	Fuller-Thomson E et al.	—	2020	→
Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method.	Sznitman SR et al.	—	2020	→
Latent classes of lifetime drug use disorder in national epidemiological survey on alcohol and related conditions - III.	Hochheimer M et al.	—	2020	→
Maternal persistent marijuana use and cigarette smoking are independently associated with shorter gestational age.	Nawa N et al.	—	2020	→
Medical marijuana laws and driving under the influence of marijuana and alcohol.	Fink DS et al.	—	2020	→
Men's health in the United States: a national health paradox.	Nuzzo JL	—	2020	→
Obsessive-Compulsive Symptoms and Cannabis Misuse: The Explanatory Role of Cannabis Use Motives.	Bakhshaie J et al.	—	2020	→
One Is Not Enough: Understanding and Modeling Polysubstance Use.	Crummy EA et al.	—	2020	→
Parents' Perceptions of Adolescent Exposure to Marijuana Following Legalization in Washington State.	Jones TM et al.	—	2020	→
Perceived safety of cannabis intoxication predicts frequency of driving while intoxicated.	Borodovsky JT et al.	—	2020	→
Periodontal Conditions and Whole Salivary IL-17A and -23 Levels among Young Adult <i>Cannabis sativa</i> (Marijuana)-Smokers, Heavy Cigarette-Smokers and Non-Smokers.	Javed F et al.	—	2020	→
Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.	Marino L et al.	—	2020	→
Persisting on the past: Cross-sectional and prospective associations between sunk cost propensity and cannabis use.	Sofis MJ et al.	—	2020	→
Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents.	Nielsen S et al.	—	2020	→
Potential of Glial Cell Modulators in the Management of Substance Use Disorders.	Jones JD	—	2020	→
Prenatal cannabinoid exposure alters the ovarian reserve in adult offspring of rats.	Castel P et al.	—	2020	→
Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome.	Siddiqui MT et al.	—	2020	→
Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.	Pacek LR et al.	—	2020	→
Retrospective cross-sectional analysis of the changes in marijuana use in the USA, 2005-2018.	Mitchell W et al.	—	2020	→
Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.	Sayre M et al.	—	2020	→
Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Δ9-Tetrahydrocannabinol.	Parks C et al.	—	2020	→
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.	Matheson J et al.	—	2020	→
Sources of Information and Beliefs About the Health Effects of Marijuana.	Ishida JH et al.	—	2020	→
State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.	McBain RK et al.	—	2020	→
Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state.	Subbaraman MS et al.	—	2020	→
Terpenoids, Cannabimimetic Ligands, beyond the <i>Cannabis</i> Plant.	Gonçalves ECD et al.	—	2020	→
The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis.	Wright A et al.	—	2020	→
The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use.	Latif Z et al.	—	2020	→
The implications of late-life cannabis use on brain health: A mapping review and implications for future research.	Weinstein G et al.	—	2020	→
The Intersection between Spliff Usage, Tobacco Smoking, and Having the First Joint after Waking.	Kumar N et al.	—	2020	→
The nephrologist's guide to cannabis and cannabinoids.	Rein JL	—	2020	→
Therapist and computer-based brief interventions for drug use within a randomized controlled trial: effects on parallel trajectories of alcohol use, cannabis use and anxiety symptoms.	Drislane LE et al.	—	2020	→
Trajectories of Driving after Drinking among Marijuana-Using Youth in the Emergency Department: Substance Use, Mental Health, and Peer and Parental Influences.	Dora-Laskey AD et al.	—	2020	→
Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up.	Stephens RS et al.	—	2020	→
Trends and mental health correlates of discrimination among Latin American and Asian immigrants in the United States.	Salas-Wright CP et al.	—	2020	→
Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States.	Lekoubou A et al.	—	2020	→
Trends in inpatient discharges with drug or alcohol admission diagnoses to a skilled nursing facility among older adults, New York City 2008-2014.	Han BH et al.	—	2020	→
U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013.	Hasin DS et al.	—	2020	→
Use of medical marijuana in cystic fibrosis patients.	Stephen MJ et al.	—	2020	→
What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis.	Leung J et al.	—	2020	→
Young Adults With Higher Motives and Expectancies of Regular Cannabis Use Show Poorer Psychosocial Functioning.	Amiet D et al.	—	2020	→
"You're Ganja Have a Good Time": Investigating the Roots of Blunt Use Among a National Sample of Hispanic Adults.	Yockey RA et al.	—	2020	→
Youth Suicide: A Population Crying for Help? A System Overloaded? Who Can Help?	Shankar R et al.	—	2020	→
Aberrant structural-functional coupling in adult cannabis users.	Kim DJ et al.	—	2019	→
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain.	Tyree GA et al.	—	2019	→
Acute Cerebral Ischemia Temporally Associated with Marijuana Use.	Viswanathan V et al.	—	2019	→
Adult substance use as a function of growth in peer use across adolescence and young adulthood in the context of ADHD: Findings from the MTA.	Kennedy TM et al.	—	2019	→
Age, period and cohort effects in frequent cannabis use among US students: 1991-2018.	Hamilton AD et al.	—	2019	→
Alcohol and Marijuana Polysubstance Use: Comparison of PTSD Symptom Endorsement and Severity Patterns.	Kearns NT et al.	—	2019	→
Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co- and tri-use.	Roche DJO et al.	—	2019	→
An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use.	Budney AJ et al.	—	2019	→
Are cannabis users less likely to gain weight? Results from a national 3-year prospective study.	Alshaarawy O et al.	—	2019	→
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.	Fischer B et al.	—	2019	→
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis.	Gobbi G et al.	—	2019	→
Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men.	Okafor CN et al.	—	2019	→
Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men.	Gorbach PM et al.	—	2019	→
Associations Between Marijuana Use and Involuntary Job Loss in the United States: Representative Longitudinal and Cross-Sectional Samples.	Okechukwu CA et al.	—	2019	→
Associations between sociodemographic characteristics and substance use disorder severity among methamphetamine-using men who have sex with men.	Anderson-Carpenter KD et al.	—	2019	→
Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status.	Philbin MM et al.	—	2019	→
A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age.	Sexton M et al.	—	2019	→
Brain activation to cannabis- and alcohol-related words in alcohol use disorder.	Müller-Oehring EM et al.	—	2019	→
Brief interventions for cannabis use in emerging adults: A systematic review, meta-analysis, and evidence map.	Halladay J et al.	—	2019	→
Building Evidence-Based Prevention Mechanisms Into Cannabis Legalization Policy and Regulations.	Johnson JK et al.	—	2019	→
Cannabis Addiction and the Brain: a Review.	Zehra A et al.	—	2019	→
Cannabis and the Current State of Treatment for Cannabis Use Disorder.	Williams AR et al.	—	2019	→
Cannabis Concentrate Use in Adolescents.	Meier MH et al.	—	2019	→
Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.	Alhamad T et al.	—	2019	→
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.	Burggren AC et al.	—	2019	→
Cannabis Influences the Putative Cytokines-Related Pathway of Epilepsy among Egyptian Epileptic Patients.	M Taalab Y et al.	—	2019	→
Cannabis Use and Anxiety Sensitivity in Relation to Physical Health and Functioning in post-9/11 Veterans.	Stewart KL et al.	—	2019	→
Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.	Santaella-Tenorio J et al.	—	2019	→
Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.	Compton WM et al.	—	2019	→
Cannabis use in older drivers in Colorado: The LongROAD Study.	DiGuiseppi CG et al.	—	2019	→
Cannabis Use in Pregnancy in British Columbia and Selected Birth Outcomes.	Luke S et al.	—	2019	→
Cannabis use patterns at the dawn of US cannabis reform.	Kumar N et al.	—	2019	→
Changing landscape of cannabis: novel products, formulations, and methods of administration.	Spindle TR et al.	—	2019	→
College attendance type and subsequent alcohol and marijuana use in the U.S.	Jang JB et al.	—	2019	→
Context matters: Characteristics of solitary versus social cannabis use.	Spinella TC et al.	—	2019	→
Controlled Substance Use Among Psychiatric Patients in a Rural North Carolina Emergency Department.	Gignac E et al.	—	2019	→
Cross-domain correlates of cannabis use disorder severity among young adults.	Schuster RM et al.	—	2019	→
Developing a phone-based measure of impairment after acute oral ∆<sup>9</sup>-tetrahydrocannabinol.	Pabon E et al.	—	2019	→
Developmental Trajectories of Opioid Use Among Juvenile Offenders: An Epidemiological Examination of Group Characteristics and Criminological Risk Factors.	Wojciechowski TW	—	2019	→
Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study.	Macatee RJ et al.	—	2019	→
DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.	Livne O et al.	—	2019	→
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.	D'Souza DC et al.	—	2019	→
Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review.	McConachie SM et al.	—	2019	→
Employment and Marijuana Use Among Washington State Adolescents Before and After Legalization of Retail Marijuana.	Graves JM et al.	—	2019	→
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22).	Jones S et al.	—	2019	→
First Time Cannabis Use and Sexual Debut in U.S. High School Adolescents.	El-Menshawi M et al.	—	2019	→
Frontal Alpha Asymmetry and Inhibitory Control among Individuals with Cannabis Use Disorders.	Shevorykin A et al.	—	2019	→
Greater risk for frequent marijuana use and problems among young adult marijuana users with a medical marijuana card.	Tucker JS et al.	—	2019	→
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.	Haney M et al.	—	2019	→
Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.	Arterberry BJ et al.	—	2019	→
Historical trends in the grade of onset and sequence of cigarette, alcohol, and marijuana use among adolescents from 1976-2016: Implications for "Gateway" patterns in adolescence.	Keyes KM et al.	—	2019	→
Identifying subtypes of cannabis users based on simultaneous polysubstance use.	Davis CN et al.	—	2019	→
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013.	Mauro CM et al.	—	2019	→
Implementing an Addiction Medicine Module-Based Educational Platform.	Athanasiou N et al.	—	2019	→
Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.	Buckner JD et al.	—	2019	→
Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.	Fischer B et al.	—	2019	→
Is Cannabis Harmless? Focus on Brain Function.	Ashton JC	—	2019	→
Is the global prevalence rate of adult mental illness increasing? Systematic review and meta-analysis.	Richter D et al.	—	2019	→
Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects.	Roberts BA	—	2019	→
Marijuana use among patients with epilepsy at a tertiary care center.	Kerr A et al.	—	2019	→
Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.	Tomko RL et al.	—	2019	→
Medical Use of Cannabis in 2019.	Hill KP	—	2019	→
Modes of cannabis use: A secondary analysis of an intensive longitudinal natural history study.	Streck JM et al.	—	2019	→
National Trends in Parental Communication With Their Teenage Children About the Dangers of Substance Use, 2002-2016.	Salas-Wright CP et al.	—	2019	→
Older Adults Driving Under the Influence: Associations With Marijuana Use, Marijuana Use Disorder, and Risk Perceptions.	Choi NG et al.	—	2019	→
Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain.	Fales JL et al.	—	2019	→
Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.	Cooke AC et al.	—	2019	→
Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids.	Frohe T et al.	—	2019	→
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.	Garcia-Romeu A et al.	—	2019	→
Perspectives on cannabis as a substitute for opioid analgesics.	Khan SP et al.	—	2019	→
Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.	Han BH et al.	—	2019	→
Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample.	Salas-Wright CP et al.	—	2019	→
Psychiatric comorbidities in alcohol use disorder.	Castillo-Carniglia A et al.	—	2019	→
Psychometric evaluation of an abbreviated version of the intragroup marginalization inventory.	Llamas J et al.	—	2019	→
Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care.	Donovan KA et al.	—	2019	→
Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health?	Weinberger AH et al.	—	2019	→
Sexual risk behavior and substance use among young, diverse women seeking care at a reproductive health clinic.	Norris AL et al.	—	2019	→
Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study.	Franco S et al.	—	2019	→
Should donors who have used marijuana be considered candidates for living kidney donation?	Ruckle D et al.	—	2019	→
Should Physicians Recommend Replacing Opioids With Cannabis?	Humphreys K et al.	—	2019	→
Six policy lessons relevant to cannabis legalization.	Shover CL et al.	—	2019	→
The Effects of Marijuana Use on Transitions through Stages of Alcohol Involvement for Men and Women in the NESARC I and II.	Green KM et al.	—	2019	→
The neuropsychopharmacology of cannabis: A review of human imaging studies.	Bloomfield MAP et al.	—	2019	→
The Prevalence and Correlates of Sexual Arrangements in a National Cohort of HIV-Negative Gay and Bisexual Men in the United States.	Starks TJ et al.	—	2019	→
The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.	Lapham GT et al.	—	2019	→
Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.	Jutras-Aswad D et al.	—	2019	→
Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.	Hasin DS et al.	—	2019	→
Tobacco and cannabis co-use and interrelatedness among adults.	Akbar SA et al.	—	2019	→
Trends in cannabis use among immigrants in the United States, 2002-2017: Evidence from two national surveys.	Salas-Wright CP et al.	—	2019	→
Trends in Opioid Misuse among Marijuana Users and Non-Users in the U.S. from 2007-2017.	Azagba S et al.	—	2019	→
Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood.	Tucker JS et al.	—	2019	→
Typology of cannabis use among adults: A latent class approach to risk and protective factors.	Manning K et al.	—	2019	→
Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review.	Ahmed S et al.	—	2019	→
Using Classification Trees to Examine Predictors of Marijuana Use Among a Wide Range of Variables.	Wallace GT et al.	—	2019	→
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?	Curran HV et al.	—	2019	→
Δ<sup>9</sup>-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture.	Rizzo MD et al.	—	2019	→
A Burning Problem: Cannabis Lessons Learned from Colorado.	Parnes JE et al.	—	2018	→
Age Differences in Daily and Nondaily Cannabis Use in the United States, 2002-2014.	Mauro PM et al.	—	2018	→
Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters.	Bahorik AL et al.	—	2018	→
A longitudinal assessment of change in marijuana use with other substance use problems.	Choi NG et al.	—	2018	→
A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.	Rabin RA et al.	—	2018	→
Approach bias modification for cannabis use disorder: A proof-of-principle study.	Sherman BJ et al.	—	2018	→
A prospective observational study of problematic oral cannabinoid use.	Ware MA et al.	—	2018	→
A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record.	Keyhani S et al.	—	2018	→
Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design.	Elkins IJ et al.	—	2018	→
Associations of Father's Lifetime Cannabis Use Disorder with Child's Initiation of Cannabis Use, Alcohol Use, and Sexual Intercourse by Child Gender.	Cho BY	—	2018	→
A Systematic Review of Marijuana Use and Outcomes in Patients with Myocardial Infarction.	Pradhan RR et al.	—	2018	→
Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.	Baker NL et al.	—	2018	→
Cannabis Addiction and the Brain: a Review.	Zehra A et al.	—	2018	→
Cannabis and Mood Disorders.	Lucatch AM et al.	—	2018	→
Cannabis for Chronic Pain: Challenges and Considerations.	Romero-Sandoval EA et al.	—	2018	→
Cannabis Legalization and Psychiatric Disorders: Caveat "Hemp-tor".	George TP et al.	—	2018	→
Cannabis Use and Hypomania in Young People: A Prospective Analysis.	Marwaha S et al.	—	2018	→
Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.	Olfson M et al.	—	2018	→
Cannabis Use, Lung Cancer, and Related Issues.	Jett J et al.	—	2018	→
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults.	Reynolds IR et al.	—	2018	→
Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.	Weinberger AH et al.	—	2018	→
Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.	Feingold D et al.	—	2018	→
Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco users.	Lovell ME et al.	—	2018	→
Commentary on Kerr et al. (2018): Marijuana, drug use, and mental health in the United States-a tale of two generations.	Keyes KM	—	2018	→
Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.	Reeves LE et al.	—	2018	→
Comprehensive interventions for reducing cannabis use.	Tirado-Muñoz J et al.	—	2018	→
Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology.	Saha TD et al.	—	2018	→
Cream of the Crop: Clinical Representativeness of Eligible and Ineligible Cannabis Users in Research.	Rosen AS et al.	—	2018	→
Declining Health-Related Quality of Life in the U.S.	Olfson M et al.	—	2018	→
Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.	Pauselli L et al.	—	2018	→
Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder.	Macatee RJ et al.	—	2018	→
Does Marijuana Contribute to Intimate Partner Aggression? Temporal Effects in a Community Sample of Marijuana-Using Couples.	Testa M et al.	—	2018	→
Drug-drug interactions as a result of co-administering Δ<sup>9</sup>-THC and CBD with other psychotropic agents.	Rong C et al.	—	2018	→
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles.	Kerridge BT et al.	—	2018	→
Effects of alcohol and cigarette use on the initiation, reinitiation, and persistence of cannabis use from adolescence to emerging adulthood.	Pampati S et al.	—	2018	→
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.	Hasin DS et al.	—	2018	→
Falling rates of marijuana dependence among heavy users.	Davenport S	—	2018	→
Gender- and age-varying associations of sensation seeking and substance use across young adulthood.	Evans-Polce RJ et al.	—	2018	→
Genome-wide association study identifies a novel locus for cannabis dependence.	Agrawal A et al.	—	2018	→
Impact of cannabis legalization on treatment and research priorities for cannabis use disorder.	Sahlem GL et al.	—	2018	→
Improving drug policy: The potential of broader democratic participation.	Ritter A et al.	—	2018	→
Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients?	McHardy I et al.	—	2018	→
Introduction to the Special Issue: Educating Social Workers about Alcohol and Other Drug Use Disorders.	Salas-Wright CP et al.	—	2018	→
Is Cannabis Use Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse? Longitudinal Data From a Representative Sample of US Adults.	Weinberger AH et al.	—	2018	→
Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population.	Kelly JF et al.	—	2018	→
Is There an Effect of Cannabis Consumption on Acute Pancreatitis?	Simons-Linares CR et al.	—	2018	→
Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study.	Auer R et al.	—	2018	→
Making Decisions with Trees: Examining Marijuana Outcomes among College Students using Recursive Partitioning.	Ad W et al.	—	2018	→
Marijuana Lung.	Leb JS et al.	—	2018	→
Marijuana's Influence on Pain Scores, Initial Weight Loss, and Other Bariatric Surgical Outcomes.	Bauer FL et al.	—	2018	→
Marijuana use among adolescent multiple tobacco product users and unique risks of dual tobacco and marijuana use.	Pulvers K et al.	—	2018	→
Marijuana Use Among Adults 50 Years or Older in the 21st Century.	Lloyd SL et al.	—	2018	→
Marijuana use and fecundability in a North American preconception cohort study.	Wise LA et al.	—	2018	→
Marijuana Use and Hypothalamic-Pituitary-Adrenal Axis Functioning in Humans.	Cservenka A et al.	—	2018	→
Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco Smokers Enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).	Morris MA et al.	—	2018	→
Marijuana use is associated with alcohol use and consequences across the first 2 years of college.	Gunn RL et al.	—	2018	→
Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring.	Bolhuis K et al.	—	2018	→
Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.	Bahorik AL et al.	—	2018	→
Medicinal versus Recreational Cannabis Use among Returning Veterans.	Metrik J et al.	—	2018	→
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.	Trigo JM et al.	—	2018	→
Negative affectivity as a mechanism underlying perceived distress tolerance and cannabis use problems, barriers to cessation, and self-efficacy for quitting among urban cannabis users.	Manning K et al.	—	2018	→
Older adults' marijuana use, injuries, and emergency department visits.	Choi NG et al.	—	2018	→
Older marijuana users' marijuana risk perceptions: associations with marijuana use patterns and marijuana and other substance use disorders.	Choi NG et al.	—	2018	→
Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design.	Hines LA et al.	—	2018	→
Passing on Pot: High School Seniors' Reasons for Not Using Marijuana as Predictors of Future Use.	Martz ME et al.	—	2018	→
Perceived barriers for cannabis cessation: Relations to cannabis use problems, withdrawal symptoms, and self-efficacy for quitting.	Zvolensky MJ et al.	—	2018	→
Personality, marijuana norms, and marijuana outcomes among college students.	Pearson MR et al.	—	2018	→
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.	Schlienz NJ et al.	—	2018	→
Positive expectancies mediate the association between sensation seeking and marijuana outcomes in at-risk young adults: A test of the acquired preparedness model.	Curry I et al.	—	2018	→
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.	Panlilio LV et al.	—	2018	→
Predictors of Adult Marijuana Use Among Parents and Nonparents.	Epstein M et al.	—	2018	→
Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy.	Coleman-Cowger VH et al.	—	2018	→
Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States.	Blanco C et al.	—	2018	→
Prevalence and motives for drugged driving among emerging adults presenting to an emergency department.	Bonar EE et al.	—	2018	→
Psychoactive substance use among first-year students in a Botswana University: pattern and demographic correlates.	Olashore AA et al.	—	2018	→
Psychosocial functioning among regular cannabis users with and without cannabis use disorder.	Foster KT et al.	—	2018	→
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.	Bhardwaj AK et al.	—	2018	→
Recent cannabis use among Veterans in the United States: Results from a national sample.	Davis AK et al.	—	2018	→
Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition.	Mooney LJ et al.	—	2018	→
Regular past year cannabis use in women veterans and associations with sexual trauma.	Browne KC et al.	—	2018	→
Religious Involvement and Marijuana Use for Medical and Recreational Purposes.	Burdette AM et al.	—	2018	→
Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users.	Sahlem GL et al.	—	2018	→
Rolling and scrolling: The portrayal of marijuana cigars (blunts) on YouTube.	Montgomery L et al.	—	2018	→
Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco.	Halvorson RT et al.	—	2018	→
Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws.	Sarvet AL et al.	—	2018	→
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.	Cooper ZD et al.	—	2018	→
Substance use disorders among immigrants in the United States: A research update.	Salas-Wright CP et al.	—	2018	→
Substance Use Disorders Among Veterans in a Nationally Representative Sample: Prevalence and Associated Functioning and Treatment Utilization.	Boden MT et al.	—	2018	→
Substance-Use Disorders in Later Life.	Lehmann SW et al.	—	2018	→
Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.	Molina BSG et al.	—	2018	→
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.	Moon AM et al.	—	2018	→
Testing the Amotivational Syndrome: Marijuana Use Longitudinally Predicts Lower Self-Efficacy Even After Controlling for Demographics, Personality, and Alcohol and Cigarette Use.	Lac A et al.	—	2018	→
The Alcohol and Other Drugs Education Program for Social Work Faculty: A Model for Immersion Training.	Lundgren L et al.	—	2018	→
The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress.	Manning K et al.	—	2018	→
The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida.	Mannes ZL et al.	—	2018	→
The challenges of 'medical cannabis' and mental health: a clinical perspective.	Newton-Howes G	—	2018	→
The impact of the legalization of recreational marijuana on college students.	Jones J et al.	—	2018	→
The Implications of Cannabis Policy Changes in Washington on Adolescent Perception of Risk, Norms, Attitudes, and Substance Use.	Blevins CE et al.	—	2018	→
The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.	Rabinowitz JA et al.	—	2018	→
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.	Mouhamed Y et al.	—	2018	→
Trends in and correlates of medical marijuana use among adults in the United States.	Han B et al.	—	2018	→
Trends in Cannabis and Cigarette Use Among Parents With Children at Home: 2002 to 2015.	Goodwin RD et al.	—	2018	→
Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.	Weinberger AH et al.	—	2018	→
Trends in Illicit Drug Use Among Smokers and Nonsmokers in the United States, 2002-2014.	Moeller SJ et al.	—	2018	→
Use of Protective Behavioral Strategies among Young Adult Veteran Marijuana Users.	Pedersen ER et al.	—	2018	→
US Epidemiology of Cannabis Use and Associated Problems.	Hasin DS	—	2018	→
What do we tell patients with coronary artery disease about marijuana use?	Khadanga S et al.	—	2018	→
Whole genome sequence study of cannabis dependence in two independent cohorts.	Gizer IR et al.	—	2018	→
Who seeks treatment for cannabis use? Registered characteristics and physical, psychological and psychosocial problem indicators among cannabis patients and matched controls.	Christiansen SG et al.	—	2018	→
A Biopsychological Model of Anti-drug PSA Processing: Developing Effective Persuasive Messages.	Hohman ZP et al.	—	2017	→
Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity.	Vasilenko SA et al.	—	2017	→
A latent class analysis of poly-marijuana use among young adults.	Krauss MJ et al.	—	2017	→
Alternative Approaches to Assessing Nonresponse Bias in Longitudinal Survey Estimates: An Application to Substance-Use Outcomes Among Young Adults in the United States.	West BT et al.	—	2017	→
A Randomized Clinical Trial Examining the Effect of Video-Based Prevention of Alcohol and Marijuana Use Among Recent Sexual Assault Victims.	Walsh K et al.	—	2017	→
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.	Gray KM et al.	—	2017	→
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana.	Richter L et al.	—	2017	→
Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study.	Sun AJ et al.	—	2017	→
Association between Nonmedical Marijuana and Pain Reliever Uses among Individuals Aged 50.	Choi NG et al.	—	2017	→
Awareness, Perception of Risk and Behaviors Related to Retail Marijuana Among a Sample of Colorado Youth.	Bull SS et al.	—	2017	→
Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review.	O'Neil ME et al.	—	2017	→
Building smart cannabis policy from the science up.	Weiss SRB et al.	—	2017	→
Cannabis and psychotic experiences.	Oh H et al.	—	2017	→
Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence.	Fuster D et al.	—	2017	→
Cannabis-Induced Acute Pancreatitis: A Systematic Review.	Barkin JA et al.	—	2017	→
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use.	Pergam SA et al.	—	2017	→
Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014.	Han B et al.	—	2017	→
Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study.	Feingold D et al.	—	2017	→
Cannabis use, attitudes, and legal status in the U.S.: A review.	Carliner H et al.	—	2017	→
Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth.	Jones JD et al.	—	2017	→
Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.	Schlienz NJ et al.	—	2017	→
Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents.	Troutt WD et al.	—	2017	→
Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users.	Jacobus J et al.	—	2017	→
Changes in the Mass-merchandise Cigar Market since the Tobacco Control Act.	Delnevo CD et al.	—	2017	→
Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions.	Martins SS et al.	—	2017	→
College student marijuana involvement: Perceptions, use, and consequences across 11 college campuses.	Pearson MR et al.	—	2017	→
Commentary: Navigating the complexities of marijuana.	Weiss SRB et al.	—	2017	→
Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.	McClure EA et al.	—	2017	→
Comparison of brief versus extended personalised feedback in an online intervention for cannabis users: Short-term findings of a randomised trial.	Copeland J et al.	—	2017	→
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets.	Vergara D et al.	—	2017	→
Daily associations between cannabis motives and consumption in emerging adults.	Bonar EE et al.	—	2017	→
Demographic trends among older cannabis users in the United States, 2006-13.	Han BH et al.	—	2017	→
Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005-2014.	Han BH et al.	—	2017	→
Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.	Amen DG et al.	—	2017	→
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups?	Sznitman SR	—	2017	→
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.	Wu LT et al.	—	2017	→
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.	Rabin RA et al.	—	2017	→
Estimated probability of becoming a case of drug dependence in relation to duration of drug-taking experience: a functional analysis approach.	Vsevolozhskaya OA et al.	—	2017	→
Evidence for Sex Convergence in Prevalence of Cannabis Use: A Systematic Review and Meta-Regression.	Chapman C et al.	—	2017	→
Explaining the declining rates of past year cannabis use in Australia: A first pass.	Ritter A et al.	—	2017	→
Frequency of Cannabis Use Among Primary Care Patients in Washington State.	Lapham GT et al.	—	2017	→
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.	Ghazarian AA et al.	—	2017	→
Health considerations in regulating marijuana in Vermont.	Chen H et al.	—	2017	→
<i>Drosophila</i>: An Emergent Model for Delineating Interactions between the Circadian Clock and Drugs of Abuse.	De Nobrega AK et al.	—	2017	→
Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.	Kim D et al.	—	2017	→
Longitudinal patterns of marijuana use across ages 18-50 in a US national sample: A descriptive examination of predictors and health correlates of repeated measures latent class membership.	Terry-McElrath YM et al.	—	2017	→
Lung Disease Associated With Marijuana Use.	Chatkin JM et al.	—	2017	→
Marijuana use among young people in an era of policy change: what does recent evidence tell us?	Salas-Wright CP et al.	—	2017	→
Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.	Ishida JH et al.	—	2017	→
Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice.	Rai HS et al.	—	2017	→
Marijuana use and serum testosterone concentrations among U.S. males.	Thistle JE et al.	—	2017	→
Medical Marijuana and Marijuana Legalization.	Pacula RL et al.	—	2017	→
Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders.	Mason BL et al.	—	2017	→
Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status.	Choi NG et al.	—	2017	→
Older adults who use or have used marijuana: Help-seeking for marijuana and other substance use problems.	Choi NG et al.	—	2017	→
Pathways linking marijuana use to substance use problems among emerging adults: A prospective analysis of young Black men.	Kogan SM et al.	—	2017	→
Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California.	Peiper NC et al.	—	2017	→
Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women.	Grant JD et al.	—	2017	→
Predictive validity of cannabis consumption measures: Results from a national longitudinal study.	Buu A et al.	—	2017	→
Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.	Kerridge BT et al.	—	2017	→
Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013.	Okafor CN et al.	—	2017	→
Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.	Wu LT et al.	—	2017	→
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.	Grant BF et al.	—	2017	→
Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States.	John WS et al.	—	2017	→
Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.	Suryadevara U et al.	—	2017	→
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.	Hser YI et al.	—	2017	→
Review: Prevalence and co-occurrence of addictions in US ethnic/racial groups: Implications for genetic research.	Luczak SE et al.	—	2017	→
Risk is still relevant: Time-varying associations between perceived risk and marijuana use among US 12th grade students from 1991 to 2016.	Terry-McElrath YM et al.	—	2017	→
Scientific Advances in Thoracic Oncology 2016.	Soo RA et al.	—	2017	→
Self-reported cognitive scales in a US National Survey: reliability, validity, and preliminary evidence for associations with alcohol and drug use.	Aharonovich E et al.	—	2017	→
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States.	Zhu H et al.	—	2017	→
Stigma and substance use disorders: an international phenomenon.	Yang LH et al.	—	2017	→
The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study.	Lee JY et al.	—	2017	→
The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.	Sznitman SR	—	2017	→
The cannabis withdrawal syndrome: current insights.	Bonnet U et al.	—	2017	→
The clinical implications of legalizing marijuana: Are physician and non-physician providers prepared?	Brooks E et al.	—	2017	→
The Influence of College Attendance on Risk for Marijuana Initiation in the United States: 1977 to 2015.	Miech RA et al.	—	2017	→
The potential impact of cannabis legalization on the development of cannabis use disorders.	Budney AJ et al.	—	2017	→
Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.	Hamilton HA et al.	—	2017	→
The role of anxiety sensitivity in the relation between anxious arousal and cannabis and alcohol use problems among low-income inner city racial/ethnic minorities.	Paulus DJ et al.	—	2017	→
The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study.	Campbell CI et al.	—	2017	→
The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014.	Carliner H et al.	—	2017	→
"They're Pretty Much Made for Blunts": Product Features That Facilitate Marijuana Use Among Young Adult Cigarillo Users in the United States.	Giovenco DP et al.	—	2017	→
Toward a Patient Registry for Cannabis Use: An Exploratory Study of Patient Use in an Outpatient Health-Care Clinic in Oregon.	Hoffman KA et al.	—	2017	→
Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.	Moon AM et al.	—	2017	→
Trends and correlates of marijuana use among late middle-aged and older adults in the United States, 2002-2014.	Salas-Wright CP et al.	—	2017	→
Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014.	Brown QL et al.	—	2017	→
Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011.	Charilaou P et al.	—	2017	→
US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013.	Hasin DS et al.	—	2017	→
Adolescent cortical thickness pre- and post marijuana and alcohol initiation.	Jacobus J et al.	—	2016	→
Attitudes, perceptions and practice of alcohol and drug screening, brief intervention and referral to treatment: a case study of New York State primary care physicians and non-physician providers.	Harris BR et al.	—	2016	→
Availability of Medical and Recreational Marijuana Stores and Neighborhood Characteristics in Colorado.	Shi Y et al.	—	2016	→
Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients.	Gubatan J et al.	—	2016	→
Cannabis use and cannabis use disorders.	Lynskey M et al.	—	2016	→
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys.	Salas-Wright CP et al.	—	2016	→
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample.	Lin LA et al.	—	2016	→
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013.	Grucza RA et al.	—	2016	→
Declining Rates of Adolescent Marijuana Use Disorders During the Past Decade May Be Due to Declining Conduct Problems.	Hopfer C	—	2016	→
Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood.	Sonon K et al.	—	2016	→
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.	Herrmann ES et al.	—	2016	→
Exercise as an adjunctive treatment for cannabis use disorder.	Brellenthin AG et al.	—	2016	→
Genetic and Environmental Factors Associated with Cannabis Involvement.	Bogdan R et al.	—	2016	→
Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks.	Sherva R et al.	—	2016	→
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana.	Hauser N et al.	—	2016	→
Keep off the grass? Cannabis, cognition and addiction.	Curran HV et al.	—	2016	→
Legalizing marijuana.	Leyton M	—	2016	→
Legal or Illegal, Cannabis Is Still Addictive.	Piomelli D et al.	—	2016	→
Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.	Compton WM et al.	—	2016	→
National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014.	Azofeifa A et al.	—	2016	→
NESARC Findings on Increased Prevalence of Marijuana Use Disorders-Consistent With Other Sources of Information.	Hasin DS et al.	—	2016	→
Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders.	Choi NG et al.	—	2016	→
Older marijuana users: Life stressors and perceived social support.	Choi NG et al.	—	2016	→
Perceived friends' use as a risk factor for marijuana use across young adulthood.	Patrick ME et al.	—	2016	→
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.	Anderson GD et al.	—	2016	→
Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.	Hasin DS et al.	—	2016	→
Prevalence and correlates of "Vaping" as a route of cannabis administration in medical cannabis patients.	Cranford JA et al.	—	2016	→
Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review.	Copeland J et al.	—	2016	→
Reasons for Marijuana Use Among Young Adults and Long-Term Associations With Marijuana Use and Problems.	Patrick ME et al.	—	2016	→
Recent Trends in the Prevalence of Marijuana Use and Associated Disorders in the United States.	Grucza RA et al.	—	2016	→
Recreational cannabis legalisation: details will determine mental health effects.	Hill KP	—	2016	→
Reprint of "Adolescent cortical thickness pre- and post marijuana and alcohol initiation".	Jacobus J et al.	—	2016	→
Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department.	Woodruff SI et al.	—	2016	→
Stressful Events and Other Predictors of Remission from Drug Dependence in the United States: Longitudinal Results from a National Survey.	McCabe SE et al.	—	2016	→
Tasty THC: Promises and Challenges of Cannabis Edibles.	Barrus DG et al.	—	2016	→
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women.	Werner KB et al.	—	2016	→
The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.	Rodriguez-Sanchez IP et al.	—	2016	→
The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD.	Metrik J et al.	—	2016	→
Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.	Haughwout SP et al.	—	2016	→
Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011.	Zhu H et al.	—	2016	→
WHY NOT POT?: A Review of the Brain-based Risks of Cannabis.	MacDonald K et al.	—	2016	→
Substance Use Disorder in Early Midlife: A National Prospective Study on Health and Well-Being Correlates and Long-Term Predictors.	Schulenberg JE et al.	—	2015	→